What happened in optometry this week: March 11 - March 15

Blog
Article

Catch up on what happened in optometry during the week of March 11-March 15.

Catch up with what Optometry Times shared this week:

Phase 2b trial complete for OAG drug-eluting contact lens from MediPrint Ophthalmics

By Martin David Harp, Associate Editor, Ophthalmology Times

MediPrint Ophthalmics has announced the completion of its glaucoma SIGHT-2, phase 2b study evaluating their LL-BMT1 versus a control group on bimatoprost 0.01% ophthalmic solution. The active-controlled, randomized, dose-finding, multi-center study evaluated the safety and efficacy of LL-BMT1 in 28 patients diagnosed with open-angle glaucoma for 3 weeks.

Read here...

Lessons learned from COVID-19: How to prepare for the next public health emergency

By Cynthia P. Ruggeiro, OD, MPH, FAAO, and Heidi Sutter, OD, MPH

Since its emergence in late 2019, the SARS-CoV-2 virus has changed lives and livelihoods and raised our awareness of the potential for circulating pathogens to disrupt our world. Although COVID-19 is still with us, we are removed enough from the early days of widespread uncertainty to start assessing what we have learned.

Read here...

Turning inexperience into expertise in fitting scleral lenses

By Jeffrey Sonsino, OD, FAAO, and Julie Lafreniere, OD, FAAO

Scleral lenses demand expertise. We can cause real harm by placing a hard piece of plastic on soft tissue. Although they require time to fit and are difficult to troubleshoot when problems arise, scleral lenses are life-changing for our patients.

Read here...

You and Eye: What optometrists need to know about low vision

By Miriam Korik, OD, and Emily Kaiser Maharjan, Assistant Managing Editor

Patrick D. Yoshinaga, OD, MPH, FAAO, professor and chief of low vision rehabilitation service at Southern California College of Optometry at Marshall B. Ketchum University joins host Miriam Korik, OD, on a deep dive into what low vision rehab entails. Assistive tech, diagnosis, occupational therapy referrals, and AI–all and more are discussed as these two experts discuss the the big picture and minutia of care for patients with low vision.

Listen here...

Organizations planning ahead with resources for total solar eclipse

By Jordana Joy, Associate Editor

A handful of organizations are already prepping for the April 8 total solar eclipse.

Prevent Blindness will be utilizing its Eclipse + Your Eyes program, which includes educational videos, materials, and toolkits for the public.1 Additionally, the American Optometric Association (AOA) is supplying materials for its member doctors and posting eye safety information to help keep the public's eyes healthy during the event.2

Read here...

Recent Videos
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Bonnie An Henderson, MD, the cofounder and program director of EnVision Summit
What was the biggest innovation in eye care in 2024?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
© 2024 MJH Life Sciences

All rights reserved.